News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hasco Medical, Inc. (HASC) Reports Insider Trading


6/6/2012 9:10:29 AM

MOBILE, AL--(Marketwire - June 06, 2012) - HASCO Medical, Inc. (OTCBB: HASC), www.HascoMed.com, a Company that conducts sales of handicap accessible vans, parts, service and rental operation in sixteen locations from Maine to Florida and sales of medical equipment and supplies in Alabama, Florida and Mississippi, announced today after releasing its financial results for the first quarter of 2012, during the allotted period in which officers and directors are free to trade, that all the officers and directors purchased shares of the Company's common stock.

"It's very exciting to see that as our top line volume and bottom line profits keep improving that the officers and directors are showing their support for our continued growth," stated Hal Compton, CEO of HASCO Medical.

Shares Purchased                                
Chairman - Harold Compton Sr.     315,789 shares
Director - William Marginson      315,789 shares
Director - Barry McCook           210,526 shares
CEO - Hal Compton Jr.             105,263 shares
COO - Alfredo Ollivierre           52,632 shares
CFO - Robyn Priest                 21,053 shares

About HASCO Medical, Inc.
HASCO Medical ("HASC" or the Company) provides products and services that dramatically improve the quality of living for its customers. The Company now consists of Southern Medical and Mobility, Inc. and Certified Medical on the DME side and Ride-Away, Mobility Freedom, Wheelchair Vans of America and Certified Auto on the Van Conversion/Rental side of the Company.

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.


Investor Contact:
MCG LLC
407-333-1255
investorinfo@morganconsultinggroup.net


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES